Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation

Detalles Bibliográficos
Autores principales: Ucciferri, Claudio, Vecchiet, Jacopo, Auricchio, Antonio, Falasca, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2022
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992614/
https://www.ncbi.nlm.nih.gov/pubmed/35444768
http://dx.doi.org/10.4084/MJHID.2022.023
_version_ 1784683764915372032
author Ucciferri, Claudio
Vecchiet, Jacopo
Auricchio, Antonio
Falasca, Katia
author_facet Ucciferri, Claudio
Vecchiet, Jacopo
Auricchio, Antonio
Falasca, Katia
author_sort Ucciferri, Claudio
collection PubMed
description
format Online
Article
Text
id pubmed-8992614
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Università Cattolica del Sacro Cuore
record_format MEDLINE/PubMed
spelling pubmed-89926142022-04-19 Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation Ucciferri, Claudio Vecchiet, Jacopo Auricchio, Antonio Falasca, Katia Mediterr J Hematol Infect Dis Scientific Letter Università Cattolica del Sacro Cuore 2022-03-01 /pmc/articles/PMC8992614/ /pubmed/35444768 http://dx.doi.org/10.4084/MJHID.2022.023 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Letter
Ucciferri, Claudio
Vecchiet, Jacopo
Auricchio, Antonio
Falasca, Katia
Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title_full Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title_fullStr Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title_full_unstemmed Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title_short Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
title_sort improving bnt162b2 mrna vaccine tolerability without efficacy loss by pidotimod supplementation
topic Scientific Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992614/
https://www.ncbi.nlm.nih.gov/pubmed/35444768
http://dx.doi.org/10.4084/MJHID.2022.023
work_keys_str_mv AT ucciferriclaudio improvingbnt162b2mrnavaccinetolerabilitywithoutefficacylossbypidotimodsupplementation
AT vecchietjacopo improvingbnt162b2mrnavaccinetolerabilitywithoutefficacylossbypidotimodsupplementation
AT auricchioantonio improvingbnt162b2mrnavaccinetolerabilitywithoutefficacylossbypidotimodsupplementation
AT falascakatia improvingbnt162b2mrnavaccinetolerabilitywithoutefficacylossbypidotimodsupplementation

Ejemplares similares